CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-12 | DeSilva Nishan M VP, Corporate Development | Grant or award · Employee Stock Option (right to buy) | +5,000 | $74.42 | $372K | 40,000 |
| 2014-02-12 | DeSilva Nishan M VP, Corporate Development | Grant or award · Employee Stock Option (right to buy) | +5,000 | $74.42 | $372K | 45,000 |
| 2014-01-21 | HIGGINS JOHN L President & CEO | Exercise or conversion | +9,000 | $21.00 | $189K | 111,099 |
| 2014-01-21 | HIGGINS JOHN L President & CEO | Exercise or conversion · Incentive Stock Option (right to buy) | −9,000 | $21.00 | $189K | 28,483 |
| 2014-01-16 | HIGGINS JOHN L President & CEO | Sale | −15,000 | $64.00 | $960K | 102,099 |
| 2013-12-31 | FOEHR MATTHEW W EVP and COO | Purchase | +84 | $33.92 | $3K | 45,013 |
| 2013-12-31 | Berkman Charles S VP, Gen. Counsel & Secretary | Purchase | +209 | $33.92 | $7K | 27,145 |
| 2013-12-12 | Sharp John P VP Finance and CFO | Exercise or conversion | +700 | $9.96 | $7K | 18,367 |
| 2013-12-12 | Sharp John P VP Finance and CFO | Sale | −700 | $53.44 | $37K | 17,667 |
| 2013-12-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −700 | 7,842 | ||
| 2013-12-12 | FOEHR MATTHEW W EVP and COO | Exercise or conversion | +6,000 | $9.97 | $60K | 50,929 |
| 2013-12-12 | FOEHR MATTHEW W EVP and COO | Sale | −6,000 | $53.40 | $320K | 44,929 |
| 2013-12-12 | FOEHR MATTHEW W EVP and COO | Exercise or conversion · Employee Stock Option (right to buy) | −6,000 | 159,000 | ||
| 2013-12-06 | Sharp John P VP Finance and CFO | Sale | −6,000 | $56.08 | $336K | 17,667 |
| 2013-11-27 | BVF PARTNERS L P/IL 10% owner | Sale | −86,435 | $57.07 | $4.9M | 324,836 |
| 2013-11-27 | BVF PARTNERS L P/IL 10% owner | Sale | −50,934 | $57.07 | $2.9M | 190,967 |
| 2013-11-27 | BVF PARTNERS L P/IL 10% owner | Sale | −27,058 | $57.07 | $1.5M | 101,523 |
| 2013-11-27 | BVF PARTNERS L P/IL 10% owner | Sale | −154,578 | $57.07 | $8.8M | 2,008,834 |
| 2013-11-26 | BVF PARTNERS L P/IL 10% owner | Sale | −119,139 | $57.57 | $6.9M | 411,271 |
| 2013-11-26 | BVF PARTNERS L P/IL 10% owner | Sale | −54,444 | $57.57 | $3.1M | 241,901 |
Page 80 of 86 · 1,712 trades